17 results
424B3
SYRS
Syros Pharmaceuticals Inc.
8 Aug 22
Prospectus supplement
5:47pm
, and results of operations, as well as its reputation.
Tyme has limited experience in litigation and other legal proceedings, but any lawsuit brought … with its Chief Executive Officer, or CEO, and Chief Financial Officer, or CFO, were named in a securities lawsuit by a purported stockholder, in which
S-4/A
SYRS
Syros Pharmaceuticals Inc.
1 Aug 22
Registration of securities issued in business combination transactions (amended)
9:01am
and second amended may discourage stockholders from bringing a lawsuit against directors for breach of their fiduciary duties. They may also reduce
S-4
921xuwpxzrwb
18 Jul 22
Registration of securities issued in business combination transactions
7:58am
425
l5i knd348x3c0hh7h
5 Jul 22
Business combination disclosure
7:14am
8-K
EX-2.1
lln3xgkg
5 Jul 22
Syros to Raise Approximately $190 Million Through Merger with TYME Technologies and Concurrent Private Placement
7:07am
8-K
EX-10.1
t9xzpl1imjvecfrl
13 Oct 21
Departure of Directors or Certain Officers
4:01pm
10-K
msi mnfznff
20 Mar 17
Annual report
12:00am
- Prev
- 1
- Next